Regeneron, Sanofi arthritis drug fails COVID-19 study – Reuters India

Regeneron, Sanofi arthritis drug fails COVID-19 study – Reuters India

Regeneron Pharmaceuticals Inc and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a U.S. study testing it in the most critically ill COVID-19 patients.

Read More…

You May Also Like